Also, it is the first study that has evaluated the expression level of IL7R, NFATc2 and RNF213 among MS groups with genetic classification, to investigate the effect of hereditary factors involved in the familial aggregation of the disease. The gene discussed is IL7R; the disease is myeloid sarcoma.